Cyclerion Therapeutics (CYCN) Current Assets (2018 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Current Assets of $4.6 million for Q4 2025, up 9.7% year-over-year from $4.2 million in Q4 2024, and down 8.49% quarter-over-quarter from $5.1 million in Q3 2025.
Cyclerion Therapeutics (CYCN) Current Assets (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Current Assets history runs 8 years deep, the most recent figure standing at $4.6 million for Q4 2025.
- In Q4 2025, Current Assets rose 9.7% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (up 9.7% YoY), while the FY2025 annual figure was $4.6 million, up 9.7% from the prior year.
- Current Assets for Q4 2025 stood at $4.6 million, down from $5.1 million in the prior quarter.
- The five-year high for Current Assets was $73.0 million in Q2 2021, with the low at $3.5 million in Q3 2024.
- The 5-year median for Current Assets is $8.2 million (2023), against an average of $20.9 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets sank 80.54% in 2023, then soared 42.76% in 2025.
- Cyclerion Therapeutics' Current Assets stood at $55.5 million in 2021, then slumped by 73.28% to $14.8 million in 2022, then tumbled by 45.86% to $8.0 million in 2023, then sank by 47.35% to $4.2 million in 2024, then advanced by 9.7% to $4.6 million in 2025.
- Business Quant data shows CYCN's Current Assets at $4.6 million in Q4 2025, $5.1 million in Q3 2025, and $4.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 1.76 Bn |
| 10 | Cyclerion Therapeutics | 12.62 Mn | 9.38 Mn | - | 4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 5.07 Mn |
| Jun 30, 2025 | 4.02 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 4.23 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 4.72 Mn |
| Mar 31, 2024 | 6.01 Mn |
| Dec 31, 2023 | 8.02 Mn |
| Sep 30, 2023 | 9.86 Mn |
| Jun 30, 2023 | 7.11 Mn |
| Mar 31, 2023 | 8.34 Mn |
| Dec 31, 2022 | 14.82 Mn |
| Sep 30, 2022 | 21.66 Mn |
| Jun 30, 2022 | 31.68 Mn |
| Mar 31, 2022 | 42.84 Mn |
| Dec 31, 2021 | 55.46 Mn |
| Sep 30, 2021 | 63.68 Mn |
| Jun 30, 2021 | 72.99 Mn |
| Mar 31, 2021 | 44.45 Mn |